Can intensity-modulated radiation therapy of the paraaortic region overcome the problems of critical organ tolerance?

Strahlentherapie und Onkologie

Volumn 181, Issue 3, 2005, Pages 185-190

  Hermesse, Johanne ^b   Devillers, Magali ^b   Deneufbourg, Jean Marie ^b   Nickers, Philippe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Domn Univ du Sart Tilman B35 ^*

Author keywords

Intensity modulated; Paraaortic; Radiotherapy

Indexed keywords

ARTICLE; BEAM THERAPY; CHROMAFFIN SYSTEM; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; KIDNEY; MEDICAL RECORD; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION RESPONSE; SAFETY; SPINAL CORD; STUDENT T TEST; TREATMENT PLANNING;

COMPUTER SIMULATION; DIGESTIVE SYSTEM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY; LIVER; NEOPLASMS; PRACTICE GUIDELINES; RADIATION TOLERANCE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL CORD;

EID: 17044380961     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-005-1324-8     Document Type: Article

References (15)

1. Aoki T, Nagata Y, Mizowaki T, et al. Clinical evaluation of dynamic arc conformal radiotherapy for paraaortic lymph node metastasis. Radiother Oncol 2003;67:113-8.
2. Bogner L, Scherer J, Treutwein M, et al. Verification of IMRT: techniques and problems. Strahlenther Onkol 2004;180:340-50.
3. De Meerleer G, Vakaet L, De Gersem W, et al. Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer. Strahlenther Onkol 2004;180:136-43.
4. Eifel PJ, Winter K, Morris M, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: an update of RTOG 90-01. Int J Radiat Oncol Biol Phys 2002;54:Suppl:1.
5. Greven M, Levenback C, Chao CKS, et al. Gynecology Cancer Working Group. Research Plan 2002-2006. Int J Radiat Oncol Biol Phys 2001;51:Suppl 2:58-9.
6. Grisby PW, Heydon K, Mutch DG, et al. Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2001;51:982-7.
7. Haie C, Pejovic MH, Gerbaulet A, et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 1988;11:101-12.
8. ICRU, International Commission on Radiation Units and Measurements, Report 50. Prescribing, recording, and reporting photon beam therapy. Washington: ICRU, 1993.
9. ICRU Report 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). Washington: ICRU, 1999.
10. Lohr F, Dobler B, Mai S, et al. Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT. Strahlenther Onkol 2003;179:557-63.
11. Portelance L, Chao KSC, Grisby PW, et al. Intensity-modulated radiation therapy reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-6.
12. Rotman M, Pajak T, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIa cervical carcinoma, ten-year treatment results of RTOG 79-20. JAMA 1995;274:387-93.
13. Saad AA, Lo SS, Han I, et al. Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis. Int J Radiat Oncol Biol Phys 2002;54:Suppl:40.
14. Varia MA, Bundy BN, Deppe G, et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynaecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998;42:1015-23.
15. Willner J, Jost A, Baier K, et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 2003;179:548-56.